BIRC5 and cancer: A study conducted by Hossain et al. confirmed that survivin is highly expressed in malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells, and upon silencing of survivin, EGCG had a greater anticancer capacity, further suggesting the importance of survivin inhibition in cancer [66].